Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24516103 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Conditions: Hypertension;   Diabetes Type 2
Interventions: Drug: Sitagliptin;   Drug: Substance P,;   Drug: bradykinin;   Drug: enalaprilat;   Drug: Glucagon-like peptide 1;   Drug: brain natriuretic peptide

Indicates status has not been verified in more than two years